AQR Capital Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,344
| Closed | -$129K | – | 2646 |
|
|
2024
Q1 | $129K | Buy |
8,344
+6,961
| +503% | +$108K | ﹤0.01% | 2314 |
|
|
2023
Q4 | $38.7K | Buy |
1,383
+631
| +84% | +$17.7K | ﹤0.01% | 2313 |
|
|
2023
Q3 | $35.8K | Sell |
752
-233
| -24% | -$11.1K | ﹤0.01% | 2298 |
|
|
2023
Q2 | $94.4K | Buy |
+985
| New | +$94.4K | ﹤0.01% | 2146 |
|
|
2022
Q4 | – | Sell |
-12,696
| Closed | -$1.63M | – | 2246 |
|
|
2022
Q3 | $1.63M | Sell |
12,696
-4,870
| -28% | -$625K | ﹤0.01% | 1295 |
|
|
2022
Q2 | $1.21M | Buy |
17,566
+4,246
| +32% | +$291K | ﹤0.01% | 1335 |
|
|
2022
Q1 | $1.9M | Buy |
13,320
+11,005
| +475% | +$1.57M | ﹤0.01% | 1213 |
|
|
2021
Q4 | $386K | Sell |
2,315
-2,352
| -50% | -$392K | ﹤0.01% | 1903 |
|
|
2021
Q3 | $650K | Buy |
4,667
+3,124
| +202% | +$435K | ﹤0.01% | 1758 |
|
|
2021
Q2 | $736K | Buy |
1,543
+517
| +50% | +$247K | ﹤0.01% | 1709 |
|
|
2021
Q1 | $423K | Sell |
1,026
-1,150
| -53% | -$474K | ﹤0.01% | 1900 |
|
|
2020
Q4 | $1.07M | Sell |
2,176
-862
| -28% | -$422K | ﹤0.01% | 1471 |
|
|
2020
Q3 | $1.72M | Buy |
+3,038
| New | +$1.72M | ﹤0.01% | 1174 |
|
|
2020
Q1 | – | Sell |
-7,157
| Closed | -$494K | – | 2103 |
|
|
2019
Q4 | $494K | Sell |
7,157
-4,585
| -39% | -$316K | ﹤0.01% | 1754 |
|
|
2019
Q3 | $942K | Buy |
+11,742
| New | +$942K | ﹤0.01% | 1535 |
|